Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Phillip Weeks"'
Autor:
Katrina Ford, Lisa Peters, Kyle L. Dawson, Tara Miller, A. Cochrane, Reda E. Girgis, Linda J. Stuckey, H. Lyster, Doug Jennings, Michelle M. Kittleson, Phillip Weeks, Stuart D. Russell, T. Tse, Janet Scheel, Maureen Flattery, Monica Colvin, Christina T. Doligalski, Robert L. Page, M. Shullo, Steven Ivulich, Tamara Claridge, Martin Schweiger, C. Yost, Kathleen E. Simpson, JoAnn Lindenfeld, T. Khuu, Christopher R. Ensor, David Weill, Anne I. Dipchand, David A. Baran, Patricia A. Uber
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:1050-1069
In 2009, the International Society for Heart and Lung Transplantation recognized the importance and challenges surrounding generic drug immunosuppression. As experience with generics has expanded and comfort has increased, substantial issues have ari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::847c93538413c280816df07dc7ef0579
https://doi.org/10.1016/j.healun.2020.06.024
https://doi.org/10.1016/j.healun.2020.06.024
Autor:
Yeunju Lee, Brian Castillo, Igor D. Gregoric, Biswajit Kar, Thomas W. Szymanski, Phillip Weeks, Sachin Kumar
Publikováno v:
ASAIO Journal. 66:e117-e120
The use of percutaneous ventricular assist devices (VADs) in the acute management of cardiogenic shock is becoming increasingly common. The Impella is a percutaneous VAD, which requires a heparin-containing purge solution to prevent thrombosis and ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::550170c4c07ed98f886345c2a2038569
https://doi.org/10.1097/mat.0000000000001126
https://doi.org/10.1097/mat.0000000000001126
Autor:
Long To, Robert J. DiDomenico, Craig J. Beavers, Toby C. Trujillo, Phillip Weeks, Steven P. Dunn, Douglas L. Jennings, Jenna F Cox
Publikováno v:
PharmacotherapyREFERENCES. 41(11)
Anticoagulation of patients treated with the Impella percutaneous mechanical circulatory support (MCS) devices is complex and lacks consistency across centers, potentially increasing the risk of complications. In order to optimize safety and efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42ed15759db54815b3f2df63e3ddabac
https://pubmed.ncbi.nlm.nih.gov/34597429
https://pubmed.ncbi.nlm.nih.gov/34597429
Autor:
Elaine Chow, Stephanie Bowman, Biswajit Kar, Athena Huang, Igor D. Gregoric, Rajko Radovancevic, Phillip Weeks, Sriram Nathan
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2:623-627
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::208de7c3cef3c02395cc20c66c86b4c2
https://doi.org/10.1002/jac5.1081
https://doi.org/10.1002/jac5.1081
Autor:
Rajko Radovancevic, Marwan F Jumean, Igor D. Gregoric, Brian E. Gulbis, Chandni J. Patel, Thomas W. Szymanski, Mateja Kaja Jezovnik, Biswajit Kar, Sriram Nathan, Phillip Weeks
Publikováno v:
Artificial organsREFERENCES. 44(11)
Gastrointestinal (GI) bleeding is a common complication following the placement of continuous-flow left ventricular assist devices (LVADs) in patients with advanced heart failure. Secondary events arising as a result of GI bleeding have not been well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1fc6617d3a766b9f7326bb682ea49e0
https://pubmed.ncbi.nlm.nih.gov/32530086
https://pubmed.ncbi.nlm.nih.gov/32530086
Autor:
Indranee Rajapreyar, Phillip Weeks, Rajko Radovancevic, Marwan F Jumean, Igor D. Gregoric, Sriram Nathan, Adam Sieg, Manish K Patel, Biswajit Kar
Publikováno v:
Journal of Thrombosis and Thrombolysis. 46:496-501
Pump thrombosis remains a serious complication of implantable ventricular assist device therapy and is associated with increased risk of morbidity and mortality. Optimal management strategies remain controversial and are guided largely by limited lit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f90e113b35da1c1e4703031085929c5
https://doi.org/10.1007/s11239-018-1725-z
https://doi.org/10.1007/s11239-018-1725-z
Autor:
Sophie Samuel, Jennifer Cortes, Miguel A. Escobar, Phillip Weeks, Andy Nguyen, Mary F. McGuire
Publikováno v:
Journal of thrombosis and thrombolysis. 49(1)
A diagnosis of heparin induced thrombocytopenia (HIT) must often be made based on clinical and laboratory evidence. This was a quasi-experimental study of patients admitted from June 2016 to October 2017. The primary endpoint was the incidence of fal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7386cf3b4e0bf1e159714c24f05996d
https://pubmed.ncbi.nlm.nih.gov/31552545
https://pubmed.ncbi.nlm.nih.gov/31552545
Autor:
Luisa Wetta, Marc G. Cribbs, Rachel G. Sinkey, Allison Hayes, Hind N. Moussa, Sabrina Kopf, Charles W. Hoopes, Jose A. Tallaj, Andrew Lenneman, Joanna M. Joly, Phillip Weeks, Sudeep Aryal, Indranee Rajapreyar, Salpy V. Pamboukian, Deepak Acharya
Publikováno v:
The journal of maternal-fetalneonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 34(9)
Pregnancy after cardiac transplantation poses immense challenges. Maternal risks include hypertensive disorders of pregnancy, rejection, and failure of the cardiac allograft that may lead to death. Fetal risks include potential teratogenic effects of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc415949357b3d22c01604a6f9a26be
https://pubmed.ncbi.nlm.nih.gov/31238747
https://pubmed.ncbi.nlm.nih.gov/31238747
Publikováno v:
Thrombosis Research. 160:66-68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaaaad7a4b67edadeca85585adb38f72
https://doi.org/10.1016/j.thromres.2017.10.017
https://doi.org/10.1016/j.thromres.2017.10.017
Autor:
Indranee Rajapreyar, Keshava Rajagopal, Christina Paruthi, Phillip Weeks, Sriram Nathan, L. Maximilian Buja, Lola Xie, Biswajit Kar, Pranav Loyalka, Bartosz Jozwik, Robert E. Brown
Publikováno v:
Progress in Transplantation. 27:65-68
Malignancy following solid organ transplant remains a significant threat to the survival of cardiac transplant recipients. Plasma cell dyscrasias including multiple myeloma have been encountered in this population, and medication treatments tradition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1573ccfd9062cf07611183b7493230ec
https://doi.org/10.1177/1526924816679842
https://doi.org/10.1177/1526924816679842